Renal Dysfunction, Rather Than Nonrenal Vascular Dysfunction, Mediates Salt-Induced Hypertension

Circulation

Volumn 133, Issue 9, 2016, Pages 894-906

  Hall, John E ^a  

^a UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIURETIC AGENT; ENDOTHELIN; PHOSPHODIESTERASE 3A; PHOSPHODIESTERASE III; SODIUM CHLORIDE; UNCLASSIFIED DRUG; SALT INTAKE;

ARTICLE; BLOOD PRESSURE REGULATION; BLOOD VOLUME; BODY FLUID; DEOXYCORTICOSTERONE-SALT INDUCED HYPERTENSION; FEEDBACK SYSTEM; GENETIC DISORDER; GENETIC HETEROGENEITY; HUMAN; HYPERTENSION; KIDNEY DYSFUNCTION; KIDNEY TRANSPLANTATION; KIDNEY TUBULE ABSORPTION; KIDNEY TUBULE PRESSURE; MONOGENIC DISORDER; MUTATION; NATRIURESIS; NONHUMAN; PRIORITY JOURNAL; RENOVASCULAR DISEASE; SALT INTAKE; SODIUM EXCRETION; SODIUM RETENTION; VASCULAR RESISTANCE; ADMINISTRATION AND DOSAGE; ADVERSE EFFECTS; ANIMAL; KIDNEY DISEASE; PATHOPHYSIOLOGY; PHYSIOLOGY; VASODILATATION;

ANIMALS; HUMANS; HYPERTENSION; KIDNEY DISEASES; SODIUM CHLORIDE, DIETARY; VASODILATION;

EID: 84959504747     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.115.018526     Document Type: Article

References (100)

1. Appel LJ, Frohlich ED, Hall JE, Pearson TA, Sacco RL, Seals DR, Sacks FM, Smith SC Jr, Vafiadis DK, Van Horn LV. The importance of population-wide sodium reduction as a means to prevent cardiovascular disease and stroke: a call to action from the American Heart Association. Circulation. 2011;123:1138-1143. doi: 10.1161/CIR.0b013e31820d0793.
2. Whelton PK, Appel LJ, Sacco RL, Anderson CA, Antman EM, Campbell N, Dunbar SB, Frohlich ED, Hall JE, Jessup M, Labarthe DR, MacGregor GA, Sacks FM, Stamler J, Vafiadis DK, Van Horn LV. Sodium, blood pressure, and cardiovascular disease: further evidence supporting the American Heart Association sodium reduction recommendations. Circulation. 2012;126:2880-2889. doi: 10.1161/CIR.0b013e318279acbf.
3. He FJ, MacGregor GA. Effect of modest salt reduction on blood pressure: a meta-analysis of randomized trials: implications for public health. J Hum Hypertens. 2002;16:761-770. doi: 10.1038/sj.jhh.1001459.
4. Kotchen TA, Cowley AW Jr, Frohlich ED. Salt in health and disease: a delicate balance. N Engl J Med. 2013;368:1229-1237. doi: 10.1056/NEJMra1212606.
5. Kotchen TA, Luke RG, Ott CE, Galla JH, Whitescarver S. Effect of chloride on renin and blood pressure responses to sodium chloride. Ann Intern Med. 1983;98(pt 2):817-822.
6. Whitescarver SA, Ott CE, Jackson BA, Guthrie GP Jr, Kotchen TA. Salt-sensitive hypertension: contribution of chloride. Science. 1984;223:1430-1432.
7. Schmidlin O, Forman A, Sebastian A, Morris RC Jr. Sodium-selective salt sensitivity: its occurrence in blacks. Hypertension. 2007;50:1085-1092. doi: 10.1161/HYPERTENSIONAHA.107.091694.
8. Kurtz TW, Al-Bander HA, Morris RC Jr. "Salt-sensitive" essential hypertension in men: is the sodium ion alone important N Engl J Med. 1987;317:1043-1048. doi: 10.1056/NEJM198710223171702.
9. Schmidlin O, Sebastian AF, Morris RC Jr. What initiates the pressor effect of salt in salt-sensitive humans Observations in normotensive blacks. Hypertension. 2007;49:1032-1039. doi: 10.1161/HYPERTENSIONAHA.106.084640.
10. Kawasaki T, Delea CS, Bartter FC, Smith H. The effect of high-sodium and low-sodium intakes on blood pressure and other related variables in human subjects with idiopathic hypertension. Am J Med. 1978;64:193-198.
11. Kurtz TW, Dominiczak AF, DiCarlo SE, Pravenec M, Morris RC Jr. Molecular-based mechanisms of mendelian forms of salt-dependent hypertension: questioning the prevailing theory. Hypertension. 2015;65:932-941. doi: 10.1161/HYPERTENSIONAHA.114.05092.
12. Guyton AC. Arterial pressure and hypertension. In: Circulatory Physiology III. Philadelphia, PA: W.B. Saunders; 1980.
13. Hall JE. The kidney, hypertension, and obesity. Hypertension. 2003;41(pt 2):625-633. doi: 10.1161/01.HYP.0000052314.95497.78.
14. Cowley AW Jr. Long-term control of arterial blood pressure. Physiol Rev. 1992;72:231-300.
15. Cowley AW Jr. The concept of autoregulation of total blood flow and its role in hypertension. Am J Med. 1980;68:906-916.
16. Weinberger MH. Salt sensitivity of blood pressure in humans. Hypertension. 1996;27(pt 2):481-490.
17. Felder RA, White MJ, Williams SM, Jose PA. Diagnostic tools for hypertension and salt sensitivity testing. Curr Opin Nephrol Hypertens. 2013;22:65-76. doi: 10.1097/MNH.0b013e32835b3693.
18. Bertram JF, Douglas-Denton RN, Diouf B, Hughson MD, Hoy WE. Human nephron number: implications for health and disease. Pediatr Nephrol. 2011;26:1529-1533. doi: 10.1007/s00467-011-1843-8.
19. Frohlich ED. The salt conundrum: a hypothesis. Hypertension. 2007;50:161-166. doi: 10.1161/HYPERTENSIONAHA.107.088328.
20. Hall JE, Mizelle HL, Hildebrandt DA, Brands MW. Abnormal pressure natriuresis: a cause or a consequence of hypertension Hypertension. 1990;15(pt 1):547-559.
21. Rossier BC, Staub O, Hummler E. Genetic dissection of sodium and potassium transport along the aldosterone-sensitive distal nephron: importance in the control of blood pressure and hypertension. FEBS Lett. 2013;587:1929-1941. doi: 10.1016/j.febslet.2013.05.013.
22. Lifton RP, Gharavi AG, Geller DS. Molecular mechanisms of human hypertension. Cell. 2001;104:545-556.
23. O'Shaughnessy KM, Karet FE. Salt handling and hypertension. J Clin Invest. 2004;113:1075-1081. doi: 10.1172/JCI21560.
24. Guyton AC, Coleman TG, Granger HJ. Circulation: overall regulation. Annu Rev Physiol. 1972;34:13-46. doi: 10.1146/annurev. ph.34.030172.000305.
25. Linz P, Santoro D, Renz W, Rieger J, Ruehle A, Ruff J, Deimling M, Rakova N, Muller DN, Luft FC, Titze J, Niendorf T. Skin sodium measured with 2 3Na MRI at 7.0 T. NMR Biomed. 2015;28:54-62. doi: 10.1002/nbm.3224.
26. Guyton AC. The surprising kidney-fluid mechanism for pressure control: its infinite gain! Hypertension. 1990;16:725-730.
27. Hall JE, Guyton AC, Brands MW. Pressure-volume regulation in hypertension. Kidney Int Suppl. 1996;55:S35-S41.
28. Hall JE, Guyton AC, Smith MJ Jr, Coleman TG. Blood pressure and renal function during chronic changes in sodium intake: role of angiotensin. Am J Physiol. 1980;239:F271-F280.
29. Hall JE, Granger JP, do Carmo JM, da Silva AA, Dubinion J, George E, Hamza S, Speed J, Hall ME. Hypertension: physiology and pathophysiology. Compr Physiol. 2012;2:2393-2442. doi: 10.1002/cphy.c110058.
30. Hall JE, Mizelle HL, Brands MW, Hildebrandt DA. Pressure natriuresis and angiotensin II in reduced kidney mass, salt-induced hypertension. Am J Physiol. 1992;262(pt 2):R61-R71.
31. Omvik P, Tarazi RC, Bravo EL. Regulation of sodium balance in hypertension. Hypertension. 1980;2:515-523.
32. Averina VA, Othmer HG, Fink GD, Osborn JW. A mathematical model of salt-sensitive hypertension: the neurogenic hypothesis. J Physiol. 2015;593:3065-3075. doi: 10.1113/jphysiol.2014.278317.
33. Mizelle HL, Montani JP, Hester RL, Didlake RH, Hall JE. Role of pressure natriuresis in long-term control of renal electrolyte excretion. Hypertension. 1993;22:102-110.
34. Hall JE, Granger JP, Smith MJ Jr, Premen AJ. Role of renal hemodynamics and arterial pressure in aldosterone "escape." Hypertension. 1984;6(pt 2):I183-I192.
35. Hall JE, Granger JP, Hester RL, Coleman TG, Smith MJ Jr, Cross RB. Mechanisms of escape from sodium retention during angiotensin II hypertension. Am J Physiol. 1984;246(pt 2):F627-F634.
36. Hall JE, Montani JP, Woods LL, Mizelle HL. Renal escape from vasopressin: role of pressure diuresis. Am J Physiol. 1986;250(pt 2):F907-F916.
37. Hall JE, Mizelle HL, Woods LL, Montani JP. Pressure natriuresis and control of arterial pressure during chronic norepinephrine infusion. J Hypertens. 1988;6:723-731.
38. Woods LL, Mizelle HL, Hall JE. Control of sodium excretion in NE-ACTH hypertension: role of pressure natriuresis. Am J Physiol. 1988;255(pt 2):R894-R900.
39. Brands MW, Hall JE. Renal perfusion pressure is an important determinant of sodium and calcium excretion in DOC-salt hypertension. Am J Hypertens. 1998;11:1199-1207.
40. Passmore JC, Whitescarver SA, Ott CE, Kotchen TA. Importance of chloride for deoxycorticosterone acetate-salt hypertension in the rat. Hypertension. 1985;7(pt 2):I115-I120.
41. Schrier RW, Howard RL. Unifying hypothesis of sodium and water regulation in health and disease. Hypertension. 1991;18(suppl):3164-3168.
42. Hyndman KA, Boesen EI, Elmarakby AA, Brands MW, Huang P, Kohan DE, Pollock DM, Pollock JS. Renal collecting duct NOS1 maintains fluidelectrolyte homeostasis and blood pressure. Hypertension. 2013;62:91-98. doi: 10.1161/HYPERTENSIONAHA.113.01291.
43. Ge Y, Bagnall A, Stricklett PK, Webb D, Kotelevtsev Y, Kohan DE. Combined knockout of collecting duct endothelin A and B receptors causes hypertension and sodium retention. Am J Physiol Renal Physiol. 2008;295:F1635-F1640. doi: 10.1152/ajprenal.90279.2008.
44. Ge Y, Bagnall A, Stricklett PK, Strait K, Webb DJ, Kotelevtsev Y, Kohan DE. Collecting duct-specific knockout of the endothelin B receptor causes hypertension and sodium retention. Am J Physiol Renal Physiol. 2006;291:F1274-F1280. doi: 10.1152/ajprenal.00190.2006.
45. Ahn D, Ge Y, Stricklett PK, Gill P, Taylor D, Hughes AK, Yanagisawa M, Miller L, Nelson RD, Kohan DE. Collecting duct-specific knockout of endothelin-1 causes hypertension and sodium retention. J Clin Invest. 2004;114:504-511. doi: 10.1172/JCI21064.
46. Ramkumar N, Ying J, Stuart D, Kohan DE. Overexpression of renin in the collecting duct causes elevated blood pressure. Am J Hypertens. 2013;26:965-972. doi: 10.1093/ajh/hpt071.
47. Jacques T, Picard N, Miller RL, Riemondy KA, Houillier P, Sohet F, Ramakrishnan SK, Büsst CJ, Jayat M, Cornière N, Hassan H, Aronson PS, Hennings JC, Hübner CA, Nelson RD, Chambrey R, Eladari D. Overexpression of pendrin in intercalated cells produces chloride-sensitive hypertension. J Am Soc Nephrol. 2013;24:1104-1113. doi: 10.1681/ASN.2012080787.
48. Cowley AW Jr, Abe M, Mori T, O'Connor PM, Ohsaki Y, Zheleznova NN. Reactive oxygen species as important determinants of medullary flow, sodium excretion, and hypertension. Am J Physiol Renal Physiol. 2015;308:F179-F197. doi: 10.1152/ajprenal.00455.2014.
49. Ying J, Stuart D, Hillas E, Gociman BR, Ramkumar N, Lalouel JM, Kohan DE. Overexpression of mouse angiotensinogen in renal proximal tubule causes salt-sensitive hypertension in mice. Am J Hypertens. 2012;25:684-689. doi: 10.1038/ajh.2012.16.
50. Pavlov TS, Levchenko V, O'Connor PM, Ilatovskaya DV, Palygin O, Mori T, Mattson DL, Sorokin A, Lombard JH, Cowley AW Jr, Staruschenko A. Deficiency of renal cortical EGF increases ENaC activity and contributes to salt-sensitive hypertension. J Am Soc Nephrol. 2013;24:1053-1062. doi: 10.1681/ASN.2012080839.
51. Langston JB, Guyton AC, Douglas BH, Dorsett PE. Effect of changes in salt intake on arterial pressure and renal function in partially nephrectomized dogs. Circ Res. 1963;12:508-512.
52. Carlström M, Wåhlin N, Sällström J, Skøtt O, Brown R, Persson AE. Hydronephrosis causes salt-sensitive hypertension in rats. J Hypertens. 2006;24:1437-1443. doi: 10.1097/01.hjh.0000234126.78766.00.
53. Carlström M, Sällström J, Skøtt O, Larsson E, Persson AE. Uninephrectomy in young age or chronic salt loading causes salt-sensitive hypertension in adult rats. Hypertension. 2007;49:1342-1350. doi: 10.1161/HYPERTENSIONAHA.107.087213.
54. Johnson RJ, Lanaspa MA, Gabriela Sánchez-Lozada L, Rodriguez-Iturbe B. The discovery of hypertension: evolving views on the role of the kidneys, and current hot topics. Am J Physiol Renal Physiol. 2015;308:F167-F178. doi: 10.1152/ajprenal.00503.2014.
55. Konishi Y, Nishiyama A, Morikawa T, Kitabayashi C, Shibata M, Hamada M, Kishida M, Hitomi H, Kiyomoto H, Miyashita T, Mori N, Urushihara M, Kobori H, Imanishi M. Relationship between urinary angiotensinogen and salt sensitivity of blood pressure in patients with IgA nephropathy. Hypertension. 2011;58:205-211. doi: 10.1161/HYPERTENSIONAHA.110.166843.
56. Nguy L, Johansson ME, Grimberg E, Lundgren J, Teerlink T, Carlström M, Lundberg JO, Nilsson H, Guron G. Rats with adenine-induced chronic renal failure develop low-renin, salt-sensitive hypertension and increased aortic stiffness. Am J Physiol Regul Integr Comp Physiol. 2013;304:R744-R752. doi: 10.1152/ajpregu.00562.2012.
57. Franco M, Tapia E, Bautista R, Pacheco U, Santamaria J, Quiroz Y, Johnson RJ, Rodriguez-Iturbe B. Impaired pressure natriuresis resulting in salt-sensitive hypertension is caused by tubulointerstitial immune cell infiltration in the kidney. Am J Physiol Renal Physiol. 2013;304:F982-F990. doi: 10.1152/ajprenal.00463.2012.
58. Koomans HA, Roos JC, Boer P, Geyskes GG, Mees EJ. Salt sensitivity of blood pressure in chronic renal failure: evidence for renal control of body fluid distribution in man. Hypertension. 1982;4:190-197.
59. Hall JE. Control of sodium excretion by angiotensin II: intrarenal mechanisms and blood pressure regulation. Am J Physiol. 1986;250(pt 2):R960-R972.
60. Coffman TM, Crowley SD. Kidney in hypertension: Guyton redux. Hypertension. 2008;51:811-816. doi: 10.1161/HYPERTENSIONAHA.105.063636.
61. Crowley SD, Coffman TM. The inextricable role of the kidney in hypertension. J Clin Invest. 2014;124:2341-2347.
62. Crowley SD, Gurley SB, Herrera MJ, Ruiz P, Griffiths R, Kumar AP, Kim HS, Smithies O, Le TH, Coffman TM. Angiotensin II causes hypertension and cardiac hypertrophy through its receptors in the kidney. Proc Natl Acad Sci USA. 2006;103:17985-17990. doi: 10.1073/pnas.0605545103.
63. Gurley SB, Riquier-Brison AD, Schnermann J, Sparks MA, Allen AM, Haase VH, Snouwaert JN, Le TH, McDonough AA, Koller BH, Coffman TM. AT1A angiotensin receptors in the renal proximal tubule regulate blood pressure. Cell Metab. 2011;13:469-475. doi: 10.1016/j. cmet.2011.03.001.
64. Sparks MA, Stegbauer J, Chen D, Gomez JA, Griffiths RC, Azad HA, Herrera M, Gurley SB, Coffman TM. Vascular type 1A angiotensin II receptors control BP by regulating renal blood flow and urinary sodium excretion. J Am Soc Nephrol. 2015;26:2953-2962. doi: ASN. 2014080816.
65. Nishimoto M, Fujita T. Renal mechanisms of salt-sensitive hypertension: contribution of two steroid receptor-associated pathways. Am J Physiol Renal Physiol. 2015;308:F377-F387. doi: 10.1152/ajprenal.00477.2013.
66. Kohan DE. Role of collecting duct endothelin in control of renal function and blood pressure. Am J Physiol Regul Integr Comp Physiol. 2013;305:R659-R668. doi: 10.1152/ajpregu.00345.2013.
67. Kohan DE, Rossi NF, Inscho EW, Pollock DM. Regulation of blood pressure and salt homeostasis by endothelin. Physiol Rev. 2011;91:1-77. doi: 10.1152/physrev.00060.2009.
68. Speed JS, Heimlich JB, Hyndman KA, Fox BM, Patel V, Yanagisawa M, Pollock JS, Titze JM, Pollock DM. Endothelin-1 as a master regulator of whole-body Na+ homeostasis. FASEB J. 2015;29:4937-4944. doi: 10.1096/fj.15-276584.
69. Rettig R, Grisk O. The kidney as a determinant of genetic hypertension: evidence from renal transplantation studies. Hypertension. 2005;46:463-468. doi: 10.1161/01.HYP.0000178189.68229.8a.
70. Dahl LK, Heine M. Primary role of renal homografts in setting chronic blood pressure levels in rats. Circ Res. 1975;36:692-696.
71. Bianchi G, Fox U, Di Francesco GF, Giovanetti AM, Pagetti D. Blood pressure changes produced by kidney cross-transplantation between spontaneously hypertensive rats and normotensive rats. Clin Sci Mol Med. 1974;47:435-448.
72. Heller J, Schubert G, Havlíckova J, Thurau K. The role of the kidney in the development of hypertension: a transplantation study in the Prague hypertensive rat. Pflugers Arch. 1993;425:208-212.
73. Kawabe K, Watanabe TX, Shiono K, Sokabe H. Influence on blood pressure of renal isografts between spontaneously hypertensive and normotensive rats, utilizing the F1 hybrids. Jpn Heart J. 1978;19:886-894.
74. Greene AS, Yu ZY, Roman RJ, Cowley AW Jr. Role of blood volume expansion in Dahl rat model of hypertension. Am J Physiol. 1990;258(pt 2):H508-H514.
75. Krieger JE, Cowley AW Jr. Prevention of salt angiotensin II hypertension by servo control of body water. Am J Physiol. 1990;258(pt 2):H994-1003.
76. Hoorn EJ, Nelson JH, McCormick JA, Ellison DH. The WNK kinase network regulating sodium, potassium, and blood pressure. J Am Soc Nephrol. 2011;22:605-614. doi: 10.1681/ASN.2010080827.
77. Palermo M, Cossu M, Shackleton CH. Cure of apparent mineralocorticoid excess by kidney transplantation. N Engl J Med. 1998;339:1787-1788. doi: 10.1056/NEJM199812103392414.
78. Khattab AM, Shackleton CH, Hughes BA, Bodalia JB, New MI. Remission of hypertension and electrolyte abnormalities following renal transplantation in a patient with apparent mineralocorticoid excess well documented throughout childhood. J Pediatr Endocrinol Metab. 2014;27:17-21. doi: 10.1515/jpem-2013-0235.
79. Botero-Velez M, Curtis JJ, Warnock DG. Brief report: Liddle's syndrome revisited: a disorder of sodium reabsorption in the distal tubule. N Engl J Med. 1994;330:178-181. doi: 10.1056/NEJM199401203300305.
80. Curtis JJ, Luke RG, Dustan HP, Kashgarian M, Whelchel JD, Jones P, Diethelm AG. Remission of essential hypertension after renal transplantation. N Engl J Med. 1983;309:1009-1015. doi: 10.1056/NEJM198310273091702.
81. Guidi E, Menghetti D, Milani S, Montagnino G, Palazzi P, Bianchi G. Hypertension may be transplanted with the kidney in humans: a long-term historical prospective follow-up of recipients grafted with kidneys coming from donors with or without hypertension in their families. J Am Soc Nephrol. 1996;7:1131-1138.
82. Carlström M, Wilcox CS, Arendshorst WJ. Renal autoregulation in health and disease. Physiol Rev. 2015;95:405-511. doi: 10.1152/physrev.00042.2012.
83. Chapman K, Holmes M, Seckl J. 11-hydroxysteroid dehydrogenases: intracellular gate-keepers of tissue glucocorticoid action. Physiol Rev. 2013;93:1139-1206. doi: 10.1152/physrev.00020.2012.
84. Ramkumar N, Stuart D, Rees S, Hoek AV, Sigmund CD, Kohan DE. Collecting duct-specific knockout of renin attenuates angiotensin IIinduced hypertension. Am J Physiol Renal Physiol. 2014;307:F931-F938. doi: 10.1152/ajprenal.00367.2014.
85. Lalioti MD, Zhang J, Volkman HM, Kahle KT, Hoffmann KE, Toka HR, Nelson-Williams C, Ellison DH, Flavell R, Booth CJ, Lu Y, Geller DS, Lifton RP. Wnk4 controls blood pressure and potassium homeostasis via regulation of mass and activity of the distal convoluted tubule. Nat Genet. 2006;38:1124-1132. doi: 10.1038/ng1877.
86. Zhang J, Patel MB, Griffiths R, Mao A, Song YS, Karlovich NS, Sparks MA, Jin H, Wu M, Lin EE, Crowley SD. Tumor necrosis factor-produced in the kidney contributes to angiotensin II-dependent hypertension. Hypertension. 2014;64:1275-1281. doi: 10.1161/HYPERTENSIONAHA.114.03863.
87. DiBona GF, Esler M. Translational medicine: the antihypertensive effect of renal denervation. Am J Physiol Regul Integr Comp Physiol. 2010;298:R245-R253. doi: 10.1152/ajpregu.00647.2009.
88. Henegar JR, Zhang Y, De Rama R, Hata C, Hall ME, Hall JE. Catheter-based radiorefrequency renal denervation lowers blood pressure in obese hypertensive dogs. Am J Hypertens. 2014;27:1285-1292. doi: 10.1093/ajh/hpu048.
89. Frohlich ED, Schnaper HW, Wilson IM, Freis ED. Hemodynamic alterations in hypertensive patients due to chlorothiazide. N Engl J Med. 1960;262:1261-1263. doi: 10.1056/NEJM196006232622502.
90. Pickkers P, Hughes AD, Russel FG, Thien T, Smits P. Thiazide-induced vasodilation in humans is mediated by potassium channel activation. Hypertension. 1998;32:1071-1076.
91. Bennett WM, McDonald WJ, Kuehnel E, Hartnett MN, Porter GA. Do diuretics have antihypertensive properties independent of natriuresis Clin Pharmacol Ther. 1977;22(pt 1):499-504.
92. Mukherjee SK, Katz MA, Michael UF, Ogden DA. Mechanisms of hemodynamic actions of furosemide: differentiation of vascular and renal effects on blood pressure in functionally anephric hypertensive patients. Am Heart J. 1981;101:313-318.
93. Hall JE. Renal function in one-kidney, one-clip hypertension and low renin essential hypertension. Am J Hypertens. 1991;4(pt 2):523S-533S.
94. Toka O, Tank J, Schächterle C, Aydin A, Maass PG, Elitok S, Bartels-Klein E, Hollfinger I, Lindschau C, Mai K, Boschmann M, Rahn G, Movsesian MA, Müller T, Doescher A, Gnoth S, Mühl A, Toka HR, Wefeld-Neuenfeld Y, Utz W, Töpper A, Jordan J, Schulz-Menger J, Klussmann E, Bähring S, Luft FC. Clinical effects of phosphodiesterase 3A mutations in inherited hypertension with brachydactyly. Hypertension. 2015;66:800-808. doi: 10.1161/HYPERTENSIONAHA.115.06000.
95. Jordan J, Toka HR, Heusser K, Toka O, Shannon JR, Tank J, Diedrich A, Stabroth C, Stoffels M, Naraghi R, Oelkers W, Schuster H, Schobel HP, Haller H, Luft FC. Severely impaired baroreflex-buffering in patients with monogenic hypertension and neurovascular contact. Circulation. 2000;102:2611-2618.
96. Schuster H, Toka O, Toka HR, Busjahn A, Oztekin O, Wienker TF, Bilginturan N, Bähring S, Skrabal F, Haller H, Luft FC. A crossover medication trial for patients with autosomal-dominant hypertension with brachydactyly. Kidney Int. 1998;53:167-172. doi: 10.1046/j.1523-1755.1998.00732.x.
97. Huang M, Hester RL, Coleman TG, Smith MJ, Guyton AC. Development of hypertension in animals with reduced total peripheral resistance. Hypertension. 1992;20:828-833.
98. Huang M, Hester RL, Guyton AC, Norman RA Jr. Hemodynamic studies in DOCA-salt hypertensive rats after opening of an arteriovenous fistula. Am J Physiol. 1992;262(pt 2):H1802-H1808.
99. Schmidlin O, Forman A, Leone A, Sebastian A, Morris RC Jr. Salt sensitivity in blacks: evidence that the initial pressor effect of NaCl involves inhibition of vasodilatation by asymmetrical dimethylarginine. Hypertension. 2011;58:380-385. doi: 10.1161/HYPERTENSIONAHA.111.170175.
100. White SW, Quail AW, de Leeuw PW, Traugott FM, Brown WJ, Porges WL, Cottee DB. Impedance cardiography for cardiac output measurement: an evaluation of accuracy and limitations. Eur Heart J. 1990;11(suppl 1):79-92.